Name: Daclatasvir Monodes(N-carboxymethyl)valine
SKU: ACI-047015
Availability: InStock

Daclatasvir Monodes(N-carboxymethyl)valine

Catalogue No.

ACI-047015

Product Description

Additional information

Additional information

Appearance

Off white powder(Highly hygroscopic)

CAS No.

1007884-60-7

Catalogue No.

ACI-047015

Melting Point

Molecular Formula

C₃₃H₃₉N₇O₃

Molecular Weight

581.71

Shipping Condition

Ambient

Storage Condition

2-8°C

Therapeutic Category

Antiviral

Recently Viewed

4-CHLORO OMEPRAZOLE SULFIDE (25 mg) (2-(((4-Chloro-3,5-dimethylpyridin-2-yl)methyl)thio)-6-methoxy-1H-benzo[d]imidazole)
Catalogue No.
1A14680
CAS No.
220757-74-4
Molecular Formula
C₁₆H₁₆ClN₃OS
Product Type
Pharmaceutical Analytical Impurities
View Details
N-FORMYL LINAGLIPTIN (25 mg) ((R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide )
Catalogue No.
1A14060
CAS No.
3037659-49-4
Molecular Formula
C₂₆H₂₈N₈O₃
Product Type
Pharmaceutical Analytical Impurities
View Details
BROMO DESONIDE (25 mg) (9α-Bromo-11β,21-dihydroxy-16α,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione)
Catalogue No.
1A13340
CAS No.
39672-77-0
Molecular Formula
C₂₄H₃₁BrO₆
Product Type
Pharmaceutical Analytical Impurities
View Details
FORMYL RAC-LINAGLIPTIN (25 mg) (N-{1-[7-(But-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]piperidin-3-yl}formamide)
Catalogue No.
1A12890
CAS No.
2137744-33-1
Molecular Formula
C₂₆H₂₈N₈O₃
Product Type
Pharmaceutical Analytical Impurities
View Details
DESISOPROPYL SELEXIPAG (25 mg) (2-{4-[(5,6-Diphenylpyrazin-2-yl)amino]butoxy}-N-(methylsulfonyl)acetamide)
Catalogue No.
1A12940
CAS No.
2928611-22-5
Molecular Formula
C₂₃H₂₆N₄O₄S
Product Type
Pharmaceutical Analytical Impurities
View Details
BIS(TRIFLUOROMETHYLBENZONITRILE) UREA (25 mg) (1,3-Bis(4-cyano-3-(trifluoromethyl)phenyl)urea )
Catalogue No.
1A13900
CAS No.
1895865-11-8
Molecular Formula
C₁₇H₈F₆N₄O
Product Type
Pharmaceutical Analytical Impurities
View Details
3'',4''-DEHYDRO TRANS-PACLITAXEL C (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(Benzoyloxy)-9-(((2R,3S)-3-((E)-hex-3-enamido)-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-3,4,4a,5,6,9,10,11,12,12a-decahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b(2aH)-diyl diacetate)
Catalogue No.
1A13220
CAS No.
2243233-98-7
Molecular Formula
C₄₆H₅₅NO₁₄
Product Type
Pharmaceutical Analytical Impurities
View Details
N-NITROSO N-METHYL HOMOVERATRYLAMINE (5 mg) (N-(3,4-Dimethoxyphenethyl)-N-methylnitrous amide)
Catalogue No.
1A11300
CAS No.
3036886-78-6
Molecular Formula
C₁₁H₁₆N₂O₃
Product Type
Pharmaceutical Analytical Impurities
View Details
VILDAGLIPTIN (100 mg) ((2S)-1-[[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]pyrrolidine- 2-carbonitrile; (2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl] -2-pyrrolidinecarbonitrile)
Catalogue No.
1800400
CAS No.
274901-16-5
Molecular Formula
C₁₇H₂₅N₃O₂
Product Type
Pharmaceutical Analytical Impurities
View Details
GLICLAZIDE (100 mg) (N-[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl]-4-methylbenzenesulfonamide; N-[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl]-4-methylbenzene-1- sulfonamide)
Catalogue No.
1800403
CAS No.
21187-98-4
Molecular Formula
C₁₅H₂₁N₃O₃S
Product Type
Pharmaceutical Analytical Impurities
View Details

Got any Queries?

We value your curiosity and strive to provide you with all the information you need. If you have any questions or need further details about our products/services, company, or any other topic related to our website, feel free to reach out to us. Our team is here to assist you promptly.

Daclatasvir Monodes(N-carboxymethyl)valine

Product Description

Product Description

Additional information

Related Products

Acebutolol Impurity G (EP)

Acebutolol Impurity G (EP)

Aceclofenac Impurity A (EP)

Aceclofenac Impurity A (EP)

Acebutolol Impurity B (EP)

Acebutolol Impurity B (EP)

Acebutolol Impurity D (EP)

Acebutolol Impurity D (EP)

Recently Viewed

4-CHLORO OMEPRAZOLE SULFIDE (25 mg) (2-(((4-Chloro-3,5-dimethylpyridin-2-yl)methyl)thio)-6-methoxy-1H-benzo[d]imidazole)

N-FORMYL LINAGLIPTIN (25 mg) ((R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide )

BROMO DESONIDE (25 mg) (9α-Bromo-11β,21-dihydroxy-16α,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione)

FORMYL RAC-LINAGLIPTIN (25 mg) (N-{1-[7-(But-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]piperidin-3-yl}formamide)

DESISOPROPYL SELEXIPAG (25 mg) (2-{4-[(5,6-Diphenylpyrazin-2-yl)amino]butoxy}-N-(methylsulfonyl)acetamide)

BIS(TRIFLUOROMETHYLBENZONITRILE) UREA (25 mg) (1,3-Bis(4-cyano-3-(trifluoromethyl)phenyl)urea )

N-NITROSO N-METHYL HOMOVERATRYLAMINE (5 mg) (N-(3,4-Dimethoxyphenethyl)-N-methylnitrous amide)

VILDAGLIPTIN (100 mg) ((2S)-1-[[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]pyrrolidine- 2-carbonitrile; (2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl] -2-pyrrolidinecarbonitrile)

GLICLAZIDE (100 mg) (N-[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl]-4-methylbenzenesulfonamide; N-[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl]-4-methylbenzene-1- sulfonamide)

Got any Queries?